BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1539745)

  • 1. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.
    White AC; Castes M; Garcia L; Trujillo D; Zambrano L
    Am J Trop Med Hyg; 1992 Feb; 46(2):123-31. PubMed ID: 1539745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
    Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
    Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.
    Abánades DR; Arruda LV; Arruda ES; Pinto JR; Palma MS; Aquino D; Caldas AJ; Soto M; Barral A; Barral-Netto M
    PLoS Negl Trop Dis; 2012; 6(6):e1687. PubMed ID: 22724032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
    Tripathi P; Ray S; Sunder S; Dube A; Naik S
    Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.
    Carvalho EM; Barral A; Pedral-Sampaio D; Barral-Netto M; Badaró R; Rocha H; Johnson WD
    J Infect Dis; 1992 Mar; 165(3):535-40. PubMed ID: 1347057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.
    Gifawesen C; Farrell JP
    Infect Immun; 1989 Oct; 57(10):3091-6. PubMed ID: 2528507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
    Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.
    Kumar P; Pai K; Tripathi K; Pandey HP; Sundar S
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1119-23. PubMed ID: 12204969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of a skin test antigen for American visceral leishmaniasis.
    Reed SG; Badaró R; Masur H; Carvalho EM; Lorenco R; Lisboa A; Teixeira R; Johnson WD; Jones TC
    Am J Trop Med Hyg; 1986 Jan; 35(1):79-85. PubMed ID: 3946739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi.
    dos Santos JI; Morgado MG; Galvão-Castro B
    Am J Trop Med Hyg; 1987 Sep; 37(2):263-70. PubMed ID: 2444121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.
    Garg R; Gupta SK; Tripathi P; Naik S; Sundar S; Dube A
    Clin Exp Immunol; 2005 Apr; 140(1):149-56. PubMed ID: 15762886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera.
    Reed SG; Badaro R; Lloyd RM
    J Immunol; 1987 Mar; 138(5):1596-601. PubMed ID: 3543131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi.
    Holaday BJ; Pompeu MM; Evans T; Braga DN; Texeira MJ; Sousa Ade Q; Sadick MD; Vasconcelos AW; Abrams JS; Pearson RD
    J Infect Dis; 1993 Feb; 167(2):411-7. PubMed ID: 8421174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma interferon production by lymphocytes from children infected with L. chagasi.
    Bacellar O; Barral-Netto M; Badaró R; Carvalho EM
    Braz J Med Biol Res; 1991; 24(8):791-5. PubMed ID: 1797267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
    Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
    Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F1 Domain of the
    Carrillo E; Fernandez L; Ibarra-Meneses AV; Santos MLB; Nico D; de Luca PM; Correa CB; de Almeida RP; Moreno J; Palatnik-de-Sousa CB
    Front Immunol; 2017; 8():750. PubMed ID: 28747911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.
    Sabur A; Bhowmick S; Chhajer R; Ejazi SA; Didwania N; Asad M; Bhattacharyya A; Sinha U; Ali N
    Front Immunol; 2018; 9():18. PubMed ID: 29441060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.